Web-based trial to evaluate the efficacy and safety of tolterodine ER 4mg in participants with overactive bladder: REMOTE trial
Contemporary Clinical TrialsPublished 2 May 2014
Miguel Orri, Craig Lipset, Bradly P. Jacobs, Anthony J. Costello, Steven R. Cummings
Citations118
SJR quartileQ1
SJR score1.00
SNIP0.74
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The REMOTE trial is the first entirely web-based trial conducted under an IND application to evaluate tolterodine extended release (ER) 4 mg for overactive bladder and the efficacy observed was consistent with results from conventional trials.
Abstract
The REMOTE trial is the first entirely web-based trial conducted under an IND application. The efficacy observed was consistent with results from conventional trials. With simplification of multi-step screening and testing, web-based trials or their component parts should provide a participant-friendly approach to many clinical trials.
Keywords
Medicine
Choice Reviews OnlineThe innovator's prescription: a disruptive solution for health care
600 Citations2009
The Innovator's Prescription applies the principles of disruptive innovation to the broken health care system with two pioneers in the field-Dr.
UrologyTolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder
459 Citations2001Philip Van Kerrebroeck, Karl J. Kreder +3 more
Tolterodine ER demonstrated an improved efficacy for reducing urge incontinence episodes and a lower frequency of dry mouth compared with the existing IR twice-daily formulation.
Nature BiotechnologyAccelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm
367 Citations2011Paul Wicks, Timothy E. Vaughan +2 more
Annals of Internal MedicineThe Sensitivity and Specificity of a Simple Test To Distinguish between Urge and Stress Urinary Incontinence
206 Citations2006Jeanette S. Brown, Catherine S. Bradley +7 more
A 3-item, self-administered questionnaire was developed to distinguish urge from stress incontinence in middle-aged and older women, with an extended evaluation as the gold standard, in classifying a broad spectrum of urinaryincontinence by type.
The American Journal of MedicineEffectiveness of glucosamine for symptoms of knee osteoarthritis: Results from an internet-based randomized double-blind controlled trial
162 Citations2004Timothy E. McAlindon, Margaret Formica +3 more
The results suggest that although glucosamine appears to be safe, it is no more effective than placebo in treating the symptoms of knee osteoarthritis.
British Journal of UrologyComparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial
159 Citations2009Sender Herschorn, Steven Swift +5 more
Study Type – Therapy (RCT)’s level of evidence’1b, and “Level of Evidence 1b” indicate that RCTs are more likely to provide positive results than placebo-controlled trials.
American Heart JournalReducing the costs of phase III cardiovascular clinical trials
140 Citations2005Eric L. Eisenstein, Philip W. Lemons +4 more
Compared with pharmaceutical companies' planned resource use and costs in Phase III cardiovascular trials, the most efficient way to reduce trial costs and still meet the trial's scientific objectives is to reduce management complexity.
MedicineAn Internet-Based Randomized, Placebo-Controlled Trial of Kava and Valerian for Anxiety and Insomnia
131 Citations2005Bradly P. Jacobs, Stephen Bent +3 more
Neither kava nor valerian relieved anxiety or insomnia more than placebo, and this trial demonstrates the feasibility of conducting randomized, blinded trials entirely via the Internet.
British Journal of UrologySuperior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head‐to‐head, placebo‐controlled trial
99 Citations2010Steven A. Kaplan, Tim Schneider +4 more
BMJConducting clinical trials over the internet: feasibility study
88 Citations2003Timothy E. McAlindon, Margaret Formica +3 more
International Urogynecology JournalEfficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women
83 Citations2008Rebecca G. Rogers, Gloria Bachmann +5 more
OAB symptoms improved with tolterodine ER as did the scores of sexual health and anxiety measures in sexually active women with OAB.
International Urogynecology JournalA new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder
47 Citations2003Steve Swift, Alan D. Garely +2 more
Toltrodine ER 4 mg once daily is effective and well tolerated in the treatment of women with overactive bladder, and reduces urge incontinence episodes more than the existing IR twice-daily formulation.
Current Medical Research and OpinionEffects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms
32 Citations2008Sender Herschorn, John Heesakkers +5 more
Improvements in subjects’ perception of their bladder-related problems and in OAB symptoms were observed as early as week 1 and a large placebo effect may have prevented the prespecified 2-category analysis of PPBC improvement from reaching statistical significance at week 12, which was the primary endpoint.
Drug Information JournalFrom Informed Consent through Database Lock: An Interactive Clinical Trial Conducted Using the Internet
16 Citations2004Kristin L. Eilenberg, Amy M. Hoover +3 more
The trial leveraged the Internet for the informed consent process, randomization, drug dispensing and accountability, safety monitoring, in-home data collection of patient-based efficacy measures, and database lock and study closure.